Beck Bode, LLC Vertex Pharmaceuticals Inc Transaction History

Beck Bode, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $7.52 Million - $9.01 Million	21,934 Added 316.01%	28,875 $11.7 Million
Q3 2023 Nov 02, 2023	SELL	$338.18 - $362.46 $37,876 - $40,595	-112 Reduced 1.59%	6,941 $2.41 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $126,711 - $141,819	-403 Reduced 5.41%	7,053 $2.48 Million
Q1 2023 May 03, 2023	SELL	$283.23 - $323.1 $337,326 - $384,812	-1,191 Reduced 13.77%	7,456 $2.35 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $391,776 - $440,749	1,371 Added 18.84%	8,647 $2.5 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $641,309 - $715,551	2,342 Added 47.47%	7,276 $2.11 Million
Q2 2022 Jul 29, 2022	BUY	$234.96 - $292.55 $955,112 - $1.19 Million	4,065 Added 467.78%	4,934 $1.39 Million
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $192,413 - $226,782	869 New	869 $227,000
Q4 2021 Feb 07, 2022	SELL	$177.01 - $223.45 $9.53 Million - $12 Million	-53,823 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$181.39 - $202.99 $9.76 Million - $10.9 Million	53,813 Added 538130.0%	53,823 $9.76 Million
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $1,874 - $2,211	10 New	10 $2,000
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $80,116 - $93,386	-387 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $98,936 - $117,299	387 New	387 $105,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.